Clavubactin vet. (Clavoral) Tafla 250/62,5 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

clavubactin vet. (clavoral) tafla 250/62,5 mg

le vet b.v.* - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 250/62,5 mg

Clavubactin vet. (Clavoral) Tafla 50/12,5 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

clavubactin vet. (clavoral) tafla 50/12,5 mg

le vet b.v.* - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 50/12,5 mg

Spectrabactin Vet Tafla 200 mg/50 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

spectrabactin vet tafla 200 mg/50 mg

dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 200 mg/50 mg

Spectrabactin Vet Tafla 40 mg/10 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

spectrabactin vet tafla 40 mg/10 mg

dechra regulatory b.v. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - tafla - 40 mg/10 mg

Keflex Mixtúrukyrni, dreifa 50 mg/ml Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

keflex mixtúrukyrni, dreifa 50 mg/ml

stada nordic aps. - cefalexinum mónóhýdrat - mixtúrukyrni, dreifa - 50 mg/ml

Keflex Tafla 500 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

keflex tafla 500 mg

stada nordic aps. - cefalexinum mónóhýdrat - tafla - 500 mg

Zinforo Unia Europejska - islandzki - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - sýklalyf fyrir almenn nota, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.